| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | SVP, Chief Commercial Officer | Chief Commercial Officer +1 more
4 companies
Cunningham Everett is a Chief Commercial Officer at EXAS, with reported holdings spanning 4 companies. Recent filings cover 0 purchases and 23 sales. Those positions are worth an estimated $16.1M at current prices.
Our model assigns Cunningham Everett a middling insider score of 54/100, based on 7 past trades. Over a 12-month horizon, 71.4% of those trades were profitable, with an average 12-month return of -4.1%.
Cunningham Everett's largest disclosed position is in DGX as SVP, Commercial, worth about $9.2M. The recent filings there lean toward selling, a net 220,870 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 10, 2018 | DGX Quest Diagnostics Inc | SVP, Commercial | Sale+OE | 40,328 | $112.00 | $4,516,736.00 | -51.3% | |
| Jul 2, 2018 | DGX Quest Diagnostics Inc | SVP, Commercial | Sale+OE | 68,069 | $109.67 | $7,465,043.15 | -64.0% | |
| May 9, 2016 | DGX Quest Diagnostics Inc | SVP, Commercial | Sale+OE | 56,312 | $76.26 | $4,294,396.04 | -63.8% | |
| May 6, 2016 | DGX Quest Diagnostics Inc | SVP, Commercial | Sale+OE | 50,447 | $76.00 | $3,833,972.00 | -61.3% |